NSE: MEDPLUS | BSE: 543427

Mid-range Performer

Download real time

843.35 -2.90 (-0.34%)

31.36% Gain from 52W Low

100.1K NSE+BSE Volume

NSE 13 Jan, 2026 3:31 PM (IST)

10,105.2

Market Cap

Market Runner Up

Beta 1Year

Low volatility

Medplus Health Services Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for MEDPLUS, BSE:543427 Medplus Health Services Ltd.

Search Inside the pdf :

Medplus Health Services Ltd.

07 Nov 2025

843.35

-0.34%

Medplus Health Services Ltd.

Buy: Medplus Health Services Ltd.

Target

Keynote Capitals Ltd

Quarterly Update Q2FY26

Medplus Health Services Ltd. is trading above all available SMAs

Medplus Health Services Ltd.

06 Aug 2025

843.35

-0.34%

Medplus Health Services Ltd

Buy: Medplus Health Services Ltd.

Target

Keynote Capitals Ltd

Quarterly Update Q1FY26

Medplus Health Servi.. has an average target of 1155.00 from 1 broker.

Medplus Health Services Ltd.

05 Feb 2025

843.35

-0.34%

Medplus Health Services Ltd

Buy: Medplus Health Services Ltd.

Target

Keynote Capitals Ltd

Quarterly Update Q3FY25

Medplus Health Servi.. has an average target of 1155.00 from 1 broker.

Medplus Health Services Ltd.

13 Jan 2025

843.35

-0.34%

Medplus Health Services Ltd

Buy: Medplus Health Services Ltd.

Keynote Capitals Ltd

Initiating Coverage Report

Medplus Health Services Ltd. is trading above all available SMAs

Medplus Health Services Ltd.

03 Jan 2022

843.35

-0.34%

Ashika - Stock Picks Medplus Health Services Ltd. - January 2022

Buy: Medplus Health Services Ltd.

Ashika Research

wellness products, including medicines, vitamins, medical devices and test kits, and (ii) fast-moving consumer goods, such as home and personal care products, including toiletries, baby care products, soaps and detergents, and sanitizers. Medplus has 3 manufacturing plants in Telangana, manufacturing range...

Medplus Health Services Ltd. is trading above all available SMAs

Medplus Health Services Ltd.

13 Dec 2021, 12:00PM

843.35

-0.34%

Medplus Health Services Limited - IPO Note - 13122021

IPO Note: Medplus Health Services Ltd.

HDFC Securities

Issue Snapshot: Issue Open: Dec 13 Dec 15 2021 Price Band: Rs. 780 796 (Discount of Rs 78 for All eligible employees) *Issue Size: Rs 1398.3 cr (Fresh issue of Rs 600 cr + Offer for sale of Rs 798.3 cr) Reservation for: QIB Upto 50% eq sh Non Institutional atleast 15% eq sh Retail atleast 35% eq sh Employee: upto Rs 5 cr Face Value: Rs 2 Book value: Rs 73.71 (Sep 30, 2021) Bid size: - 18 equity shares and in multiples thereof 100% Book built Issue Medplus Health Services Limited - IPO Note

Medplus Health Services Ltd. is trading above all available SMAs

Medplus Health Services Ltd.

13 Dec 2021

843.35

-0.34%

MedPlus Health Services Ltd. IPO Note

IPO Note: Medplus Health Services Ltd.

Ashika Research

18 Equity Shares and in multiples thereof. Public issue of 17,566,520 Equity shares of Face value Rs. 2 each, (Comprising of fresh issue of 7,537,688 Equity Shares* (Rs. 600 cr.) and Offer for Sale of...

Medplus Health Servi.. has an average target of 1155.00 from 1 broker.

Medplus Health Services Ltd.

13 Dec 2021

843.35

-0.34%

MEDPLUS HEALTH SERVICES LTD

IPO Note: Medplus Health Services Ltd.

Ventura

IPO NOTE

Medplus Health Servi.. has an average target of 1155.00 from 1 broker.

Medplus Health Services Ltd.

13 Dec 2021

843.35

-0.34%

Medplus Health Services Limited

IPO Note: Medplus Health Services Ltd.

Hem Securities

Medplus Health Services is the second largest pharmacy retailer in India, in terms of (i) revenue from operations for the financial year 2021, and (ii) number of stores as of March 31, 2021. Company offer a wide range of products, including (i) pharmaceutical and wellness products, including medicines, vitamins, medical devices and test kits, and (ii) fast-moving consumer goods, such as home and personal care products,...

Medplus Health Servi.. has an average target of 1155.00 from 1 broker.

VOTE: Is Medplus Health Services Ltd. worth buying?

73 Votes:

Buy 90.41%

Sell 4.11%

Hold 5.48%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf